drugset / Trial / NCT01081912
Phase 3 Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Low Back Pain
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to evaluate the safety and efficacy of Hydrocodone Bitartrate controlled-release capsules in subjects with chronic low back pain.
Timeline
- Start
- 2010-03
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | hydrocodone bitartrate | Unknown | 10 mg | — |
| Comparator | hydrocodone bitartrate | Unknown | 20 mg | — |
| Comparator | hydrocodone bitartrate | Unknown | 30 mg | — |
| Comparator | hydrocodone bitartrate | Unknown | 40 mg | — |
| Comparator | hydrocodone bitartrate | Unknown | 50 mg | — |
Indications
No indication recorded.